Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

July 15, 2023; Volume 20,Issue 7
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Chai, Ruichao

    1. You have access
      Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
      Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang and Ruichao Chai
      Cancer Biology & Medicine July 2023, 20 (7) 537; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0227
  2. Chang, Xin

    1. You have access
      Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
      Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang and Ruichao Chai
      Cancer Biology & Medicine July 2023, 20 (7) 537; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0227
  3. Chen, Jing

    1. You have access
      Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
      Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang and Ruichao Chai
      Cancer Biology & Medicine July 2023, 20 (7) 537; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0227
  4. Chen, Zefang

    1. You have access
      Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity
      Zefang Chen, Xinyu Cheng, Li Yang, Xiaoming Cheng, Bo Zhu and Haixia Long
      Cancer Biology & Medicine July 2023, 20 (7) 477-482; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0203
  5. Cheng, Xiaoming

    1. You have access
      Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity
      Zefang Chen, Xinyu Cheng, Li Yang, Xiaoming Cheng, Bo Zhu and Haixia Long
      Cancer Biology & Medicine July 2023, 20 (7) 477-482; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0203
  6. Cheng, Xinyu

    1. You have access
      Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity
      Zefang Chen, Xinyu Cheng, Li Yang, Xiaoming Cheng, Bo Zhu and Haixia Long
      Cancer Biology & Medicine July 2023, 20 (7) 477-482; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0203
  7. Codony-servat, Jordi

    1. You have access
      Biological insights in non-small cell lung cancer
      Rafael Rosell, Anisha Jain, Jordi Codony-Servat, Eloisa Jantus-Lewintre, Blake Morrison, Jordi Barretina Ginesta and María González-Cao
      Cancer Biology & Medicine July 2023, 20 (7) 500-518; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0108
  8. Du, Sicheng

    1. You have access
      Current progress in cancer treatment by targeting FGFR signaling
      Sicheng Du, Ying Zhang and Jianming Xu
      Cancer Biology & Medicine July 2023, 20 (7) 490-499; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0137
  9. Du, Yutong

    1. You have access
      A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids
      Ruixin Yang, Yutong Du, Wingyan Kwan, Ranlin Yan, Qimeng Shi, Lu Zang, Zhenggang Zhu, Jianming Zhang, Chen Li and Yingyan Yu
      Cancer Biology & Medicine July 2023, 20 (7) 519-536; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0099
  10. Ginesta, Jordi Barretina

    1. You have access
      Biological insights in non-small cell lung cancer
      Rafael Rosell, Anisha Jain, Jordi Codony-Servat, Eloisa Jantus-Lewintre, Blake Morrison, Jordi Barretina Ginesta and María González-Cao
      Cancer Biology & Medicine July 2023, 20 (7) 500-518; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0108
« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 20 (7)
Cancer Biology & Medicine
Vol. 20, Issue 7
15 Jul 2023
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire